Nurix Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRIX and other ETFs, options, and stocks.About NRIX
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases.
CEOArthur T. Sands
CEOArthur T. Sands
Employees286
Employees286
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2009
Founded2009
Employees286
Employees286
NRIX Key Statistics
Market cap1.99B
Market cap1.99B
Price-Earnings ratio-6.42
Price-Earnings ratio-6.42
Dividend yield—
Dividend yield—
Average volume1.40M
Average volume1.40M
High today—
High today—
Low today—
Low today—
Open price$18.88
Open price$18.88
Volume0.00
Volume0.00
52 Week high$22.50
52 Week high$22.50
52 Week low$8.18
52 Week low$8.18
Stock Snapshot
The current Nurix Therapeutics(NRIX) stock price is $19.04, with a market capitalization of 1.99B. The stock trades at a price-to-earnings (P/E) ratio of -6.42.
Nurix Therapeutics(NRIX) stock opened on 2026-01-15 at $18.88. The price climbed to — and dipped to —.
The Nurix Therapeutics(NRIX)'s current trading volume is 0, compared to an average daily volume of 1.4M.
During the past year, Nurix Therapeutics(NRIX) stock moved between $8.18 at its lowest and $22.50 at its peak.
During the past year, Nurix Therapeutics(NRIX) stock moved between $8.18 at its lowest and $22.50 at its peak.
Analyst ratings
100%
of 17 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NRIX. This list is generated using Robinhood data, and it’s not a recommendation.